You are here

Journal of Circulating Biomarkers

Journal of Circulating Biomarkers


eISSN: 18494544 | ISSN: 18494544 | Current volume: 8 | Current issue: 1

Journal of Circulating Biomarkers is an international, peer-reviewed, open access scientific journal focusing on all aspects of the rapidly growing field of circulating blood-based biomarkers and diagnostics using circulating protein and lipid markers, circulating tumor cells (CTC), circulating cell-free DNA (cfDNA) and extracellular vesicles, including exosomes, microvesicles, microparticles, ectosomes and apoptotic bodies. Please see the Aims and Scope tab for further information.

This journal is a member of the Committee on Publication Ethics (COPE).

Why publish in Circulating Biomarkers?

  • Expert international Editorial Board
  • Rigorous peer review of your scholarly work
  • Rapid online publication

Open access article processing charge (APC) information

The APC for this journal is currently an introductory rate of $1500 USD discounted from the full rate of $2000. This introductory rate is available for a limited time.

The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.

Submission information

Submit your manuscript today at http://mc.manuscriptcentral.com/jnlcb

Please see the Submission Guidelines tab for more information on how to submit your article to the journal.

Contact

Please direct any queries to Philippa.stevens@sagepub.co.uk

Journal of Circulating Biomarkers is an international, peer-reviewed, open access scientific journal focusing on all aspects of the rapidly growing field of circulating blood-based biomarkers and diagnostics using circulating protein and lipid markers, circulating tumor cells (CTC), circulating cell-free DNA (cfDNA) and extracellular vesicles, including exosomes, microvesicles, microparticles, ectosomes and apoptotic bodies. The journal publishes high-impact articles that deal with all fields related to circulating biomarkers and diagnostics, ranging from basic science to translational and clinical applications. Papers from a wide variety of disciplines are welcome; interdisciplinary studies are especially suitable for this journal.

Included within the scope are a broad array of specialties including (but not limited to) cancer, immunology, neurology, metabolic diseases, cardiovascular medicine, regenerative medicine, nosology, physiology, pathology, technological applications in diagnostics, therapeutics, vaccine, drug delivery, regenerative medicine, drug development and clinical trials. The journal also hosts reviews, perspectives and news on specific topics.

All submitted articles considered suitable for Journal of Circulating Biomarkers are subjected to rigorous peer review to ensure the highest levels of quality. The review process is carried out as quickly as possible to minimize any delays in the online publication of articles.

Submissions are encouraged from all institutions and on all topics related to circulation protein and lipid markers, CTC, cfDNA and extracellular vesicles, including:

  • technical development and clinical application of circulating protein and lipid markers
  • technical advances in isolation, purification and characterization of CTC, cfDNA, exosomes and other extracellular vesicles
  • clinical applications of CTCs, circulating cell free DNA and extracellular vesicles
  • use of CTCs, cfDNA, exosomes and extracellular vesicles in diagnostics and companion diagnostics
  • use of extracellular vesicles in therapeutics delivery, antigen presentation and vaccine development
  • design and production of cell-derived vesicles and synthetic vesicles
  • biogenesis of extracellular vesicles, both in eukaryotic and prokaryotic cells
  • mechanisms of vesicle: cell interactions intercellular signaling
  • intercellular traffic of proteins, nucleic acids and other macromolecules
  • modulation of the extracellular matrix
  • roles of extracellular vesicles in normal physiological processes, including differentiation, development, immunity, tissue repair, stem cell biology, etc.
  • roles of extracellular vesicles in disease, including cancer, neurodegeneration, diabetes, chronic inflammatory diseases, cardiovascular diseases, infectious disease, ageing, etc.
  • virology and bacteriology
  • use of extracellular vesicles in association with other synthetic nanoparticle for different scopes
Editor-in-Chief
Prof. Winston Kuo CloudHealth Genomics, Ltd., China
Associate Editor
Hang Hubert Yin University of Colorado Boulder, USA
Associate Editors
Prof. Roger Chammas Universidade de Sao Paulo, Brazil
Dr. Alain Charest Harvard University Medical School, USA
Dr. Clark Chen University of Minnesota Medical Center, USA
Dr. Stefano Fais Istituto Superiore di Sanità (National Institute of Health), Italy
Ionita Ghiran Beth Israel Deaconess Medical Center, USA
Dr. Daniel Haber Massachusetts General Hospital Cancer Center, USA
Dr. Nancy Raab-Traub University of North Carolina School of Medicine, USA
Prof. Lawrence Rajendran University of Zurich, Switzerland
Dr. John Sinden ReNeuron, UK
Dr. Johan Skog Exosome Diagnostics, USA
Dr. David T. Wong University of California-Los Angeles, USA
Dr. Alexander Vlassov Thermo Fisher Scientific, USA
Editorial Board Member
Dr. Leonora Balaj Massachusetts General Hospital, USA
Pauline Carnell-Morris Malvern Instruments Limited, UK
Dr Cesar Castro Massachusetts General Hospital Cancer Center, USA
Chih Chen National Tsing Hua University, Taiwan
Pui-Wah Choi Arbele Ltd, Hong Kong
Dr. Emanuele Cocucci Comprehensive Cancer Center, The Ohio State University, USA
Dr. Utkan Demirci Stanford University, USA
Dr. Dolores Di Vizio Harvard Medical School , USA
Jiang He University of Virginia, USA
Dr. Stefan Holdenrieder University of Bonn, Germany
Dr. Alexander Ivanov Northeastern University, USA
Dr. Hongjun Kang Tulane University, China
Dr. Shlomit Kenigsberg CReATe Fertility Centre, Canada
Dr. Mehmet Kesimer The University of North Carolina at Chapel Hill, USA
Dr Miroslaw Kornek Saarland University, Germany
Prof. Masahiko Kuroda Tokyo Medical University, Japan
Dr. Heedoo Lee Pulmonary Center, Boston University of Medicine, USA
Dr. Marcis Leja University of Latvia, Latvia
Dr. Sai-Kiang Lim Institute of Medical Biology, Singapore
Dr. Aija Line Latvian Biomedical Research and Study Centre, Riga, Latvia
Dr. Jan Lotvall University of Gothenberg, Sweden
Dr. Todd Lowe University of California – Santa Cruz, USA
Dr. Pierre-Yves Mantel University of Fribourg, Switzerland
Dr. David Meckes Florida State University, USA
Dr. Shannon Pendergrast Ymir Genomics Ltd. USA
Dr. Eva Rohde University Hospital Salzburg, Austria
Dr. Shivani Sharma University of California-Los Angeles, USA
Dr. Zacharias Suntres Northern Ontario School of Medicine, Canada
Yaoliang Tang Augusta University, USA
Dr. John C Tigges Beth Israel Deaconess Medical Center, USA
Dr Gareth Willis Boston Children's Hospital, USA
Dr. Matthew J. Wood University of Oxford, UK
Cindy Yamamoto Hitachi Chemical Co. America, Ltd, USA
Hubert Yin University of Colorado Boulder, USA
Dr. Bruce Zetter Harvard Medical School , USA
Prof. Huang-ge Zhang School of Medicine University of Louisville, USA
Dr. Hanyu Zhu Chinese PLA General Hospital, China
  • Directory of Open Access Journals (DOAJ)
  • PubMed Central (PMC)
  • Journal of Circulating Biomarkers has transferred to AboutScience SRL. For more information, please visit their website. SAGE Publishing will continue to host back issues here